Connect
MJA
MJA

Hormone replacement therapy: to use or not to use?

Michael D Coory
Med J Aust 2003; 179 (7): . || doi: 10.5694/j.1326-5377.2003.tb05607.x
Published online: 6 October 2003

Michael D Coory


  • Queensland Health, GPO Box 48, Brisbane, QLD 4001.



  • 1. Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
  • 2. Baber RJ, O’Hara JL, Boyle FM. Hormone replacement therapy: to use or not to use? Med J Aust 2003; 178: 630-633. <MJA full text>
  • 3. Patel A, Norton R, MacMahon S. The HRT furore: getting the message right [editorial]. Med J Aust 2002; 177: 345-346. <MJA full text>
  • 4. Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. JAMA 2002; 288: 366-367.
  • 5. Perneger TV. What’s wrong with Bonferroni adjustments? BMJ 1998; 316: 1236-1238.
  • 6. Sackett DL. The arrogance of preventive medicine. CMAJ 2002; 167: 363-364.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.